JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 83 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $258,000 | +239.5% | 29,536 | +29.0% | 0.22% | +278.9% |
| Q3 2019 | $76,000 | -59.8% | 22,904 | -40.1% | 0.06% | -51.3% |
| Q2 2019 | $189,000 | -39.8% | 38,222 | -24.5% | 0.12% | -9.3% |
| Q1 2019 | $314,000 | +15.4% | 50,622 | -37.3% | 0.13% | +13.2% |
| Q4 2018 | $272,000 | +30.1% | 80,710 | +151.5% | 0.11% | -30.9% |
| Q3 2018 | $209,000 | -74.8% | 32,086 | -70.4% | 0.16% | -27.6% |
| Q2 2018 | $831,000 | – | 108,517 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |